Showing results (881-890 of 1,555) with videos related to

Sort By:
Pageof 156
Disease Models & Mechanisms|September 1, 2025
The importance of imperfect pre-clinical models in adolescent idiopathic scoliosisDiane S Sepich, Ryan S Gray, Nadav Ahituv, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2012
Systematic kinome shRNA screening identifies CDK11 (PITSLRE) kinase expression is critical for osteosarcoma cell growth and proliferationZhenfeng Duan, Jianming Zhang, Edwin Choy, et al.
Seizure|August 18, 2012
Transsylvian selective amygdalohippocampectomy in children with hippocampal sclerosis: seizure, intellectual and memory outcomeAnne E Beaton, Andrew Durnford, Phillip E Heffer-Rahn, et al.
Clinical Genetics|December 1, 1993
Restrictive dermopathy: a disorder of skin differentiation with abnormal integrin expressionJ C Dean, E S Gray, K N Stewart, et al.
Elife|September 29, 2023
The Reissner fiber under tension in vivo shows dynamic interaction with ciliated cells contacting the cerebrospinal fluidCeline Bellegarda, Guillaume Zavard, Lionel Moisan, et al.
ACS Chemical Biology|September 22, 2015
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung CancerHideki Terai, Li Tan, Ellen M Beauchamp, et al.
The Journal of Nutrition|July 15, 2026
Eicosapentaenoic acid derived oxylipin incorporation into tissues of high fat diet fed mice and its consequences for n-6 PUFA derived oxylipinsBrooke E Bathon, Umar Chaudhry, Rosemary S Gray, et al.
Cancer Research|October 16, 1999
Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvantK Sturmhoefel, K Lee, G S Gray, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 1999
Immune response enhancement by in vivo administration of B7.2Ig, a soluble costimulatory proteinH Swiniarski, K Sturmhoefel, K Lee, et al.
Expert Review of Anticancer Therapy|February 25, 2003
Antibody-based therapeutics in oncologyJeffreys Ross, Karen Gray, David Schenkein, et al.
Pageof 156